Group 1 - As of August 22, 2025, Kunming Pharmaceutical Group's stock price is 14.39 yuan, down 0.07 yuan or 0.48% from the previous trading day [1] - The trading volume on that day was 233,900 hands, with a transaction amount of 335 million yuan and a turnover rate of 3.09%, resulting in a total market capitalization of 10.893 billion yuan [1] - Kunming Pharmaceutical Group operates in the traditional Chinese medicine sector of the pharmaceutical manufacturing industry, focusing on drug research, production, and sales, with products covering cardiovascular, anti-malarial, and anti-tumor fields [1] Group 2 - The latest semi-annual report indicates that Kunming Pharmaceutical Group received increased holdings from several long-term funds in the second quarter, including the National Social Security Fund, the Monetary Authority of Macao, and the Kuwait Investment Authority, which became top ten circulating shareholders [1] - The National Social Security Fund holds 10.292 million shares, the Monetary Authority of Macao holds 8.7643 million shares, and the Kuwait Investment Authority holds 5.659 million shares, while Central Huijin holds 11.815 million shares [1] - On August 22, 2025, the net outflow of main funds from Kunming Pharmaceutical Group was 12.4156 million yuan, accounting for 0.11% of the circulating market value, with a cumulative net outflow of 105 million yuan over the past five trading days, representing 0.96% of the circulating market value [1]